Skip to main content
. Author manuscript; available in PMC: 2020 Nov 12.
Published in final edited form as: N Engl J Med. 2020 Nov 12;383(20):1932–1940. doi: 10.1056/NEJMoa2002276

Table 1.

Relative incidence of intussusception in the risk periods after first, second and third doses of Rotavac® vaccine in age-eligible Indian infants (n=589) between 28-365 days of age with a confirmed history of having received or not received rotavirus vaccination by the self-controlled case series method.

Doses of rotavirus vaccine Risk Period (days) No. of cases in risk period RI (95% CI)
Dose 1 1-7 days 2 0.83 (0.0-3.00)
8-21 days 2 0.35 (0.0-1.09)
1-21 days 4 0.52 (0.08-1.27)
Dose 2 1-7 days 4 0.86 (0.20-2.15)
8-21 days 15 1.23 (0.60-2.10)
1-21 days 19 1.13 (0.61-1.94)
Dose 3 1-7 days 15 1.65 (0.82-2.64)
8-21 days 22 1.08 (0.69-1.73)
1-21 days 37 1.24 (0.81-1.82)
#

The date of intussusception was considered as the date of onset of symptoms

*

Of 589 children included in the analysis, 377 (64%) were vaccinated with 1 or more dose and 212 (36%) did not receive any dose of the rotavirus vaccine under study.